188 related articles for article (PubMed ID: 34396448)
21. Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity.
Li L; Yang L; Cheng S; Fan Z; Shen Z; Xue W; Zheng Y; Li F; Wang D; Zhang K; Lian J; Wang D; Zhu Z; Zhao J; Zhang Y
Mol Cancer; 2019 Jun; 18(1):108. PubMed ID: 31221150
[TBL] [Abstract][Full Text] [Related]
22. MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.
Li Y; Zhang H; Fan L; Mou J; Yin Y; Peng C; Chen Y; Lu H; Zhao L; Tao Z; Chen J; Wang Y; Qi X; Huang R; Ren J
Oncogene; 2020 Apr; 39(17):3473-3488. PubMed ID: 32108166
[TBL] [Abstract][Full Text] [Related]
23. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
[TBL] [Abstract][Full Text] [Related]
24. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-106b-5p inhibits growth and progression of lung adenocarcinoma cells by downregulating IGSF10.
Ling B; Liao X; Tang Q; Ye G; Bin X; Wang J; Pang Y; Qi G
Aging (Albany NY); 2021 Jul; 13(14):18740-18756. PubMed ID: 34351868
[TBL] [Abstract][Full Text] [Related]
26. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
Feng H; Zhang Z; Qing X; French SW; Liu D
Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR-578.
Wang M; Ma M; Yang Y; Li C; Wang Y; Sun X; Wang M; Sun Y; Jiao W
Thorac Cancer; 2021 Aug; 12(16):2258-2264. PubMed ID: 34236145
[TBL] [Abstract][Full Text] [Related]
28. microRNA-1205 promotes cell growth by targeting APC2 in lung adenocarcinoma.
Dai B; Kong DL; Tian J; Liu TW; Zhou H; Wang ZF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1125-1133. PubMed ID: 30779081
[TBL] [Abstract][Full Text] [Related]
29. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
Wang Q; Li M; Yang M; Yang Y; Song F; Zhang W; Li X; Chen K
Aging (Albany NY); 2020 Feb; 12(4):3312-3339. PubMed ID: 32091408
[TBL] [Abstract][Full Text] [Related]
30. LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis.
Zhu Y; Bo H; Chen Z; Li J; He D; Xiao M; Xiang L; Jin L; Zhou J; Gong L; Zhou Y; Zhou M; Xiong W; Xing X; Li R; Cao K
Aging (Albany NY); 2020 Nov; 12(21):21904-21922. PubMed ID: 33147570
[TBL] [Abstract][Full Text] [Related]
31. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
Liu T; Yang C; Wang W; Liu C
Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
[TBL] [Abstract][Full Text] [Related]
33. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
Li H; Tong L; Tao H; Liu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
[TBL] [Abstract][Full Text] [Related]
35. MiR-188 inhibits proliferation and promotes apoptosis of lung adenocarcinoma cells by targeting SIX1 to negatively regulate ERK signaling pathway.
Lv DQ; Li HY; Wu XM; Lin L; Yan SQ; Guo QY
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):721-727. PubMed ID: 32016974
[TBL] [Abstract][Full Text] [Related]
36. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling.
Zhao M; Xin XF; Zhang JY; Dai W; Lv TF; Song Y
Cancer Med; 2020 Feb; 9(3):1196-1208. PubMed ID: 31860169
[TBL] [Abstract][Full Text] [Related]
37. Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p.
Liu Y; Zhang G; Chen H; Wang H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33269379
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma.
Li L; Yang L; Fan Z; Xue W; Shen Z; Yuan Y; Sun X; Wang D; Lian J; Wang L; Zhao J; Zhang Y
Signal Transduct Target Ther; 2020 May; 5(1):54. PubMed ID: 32439898
[TBL] [Abstract][Full Text] [Related]
39. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
Li W; Pan T; Jiang W; Zhao H
Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Su Y; Shetty A; Jiang F
Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
